Vitamins on Semaglutide: Biomarker-Guided Supplementation

Last reviewed: May 29, 2026

Last updated: May 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide significantly reduces appetite and food intake, which can deplete critical micronutrients including B12, folate, iron, and calcium. Studies show GLP-1 users require targeted supplementation to prevent deficiencies that may compromise energy, bone health, and metabolic function during treatment.

At PlexusDx, we emphasize precision wellness: understanding your individual nutritional vulnerabilities helps you work with your provider to create a supplementation plan aligned with your genetic predispositions and treatment goals, not generic recommendations.

How Semaglutide Affects Nutrient Absorption and Demand

Semaglutide slows gastric emptying and reduces overall caloric intake, limiting the total nutrient your body receives from food. Additionally, reduced stomach acid and altered intestinal transit can impair absorption of nutrients like B12 and iron, both critical for energy and oxygen transport.

Long-term GLP-1 therapy users report increased fatigue, weakness, and hair loss—common signs of B12, iron, or protein deficiency. Baseline nutrient levels and genetic factors affecting absorption pathways influence how quickly deficiencies develop and which micronutrients warrant priority supplementation.

Core Micronutrients and Evidence-Based Supplementation Guidelines

Research and clinical practice guidelines identify five micronutrients requiring particular attention during GLP-1 therapy. Understanding dosage ranges, timing, and biomarker indicators helps you and your provider create an effective supplementation strategy tailored to your baseline status.

Micronutrient	Why It Matters on Semaglutide	Typical Dosing Range	Monitoring Consideration
Vitamin B12	Reduced intrinsic factor and absorption; deficiency causes fatigue and neuropathy	500–2,000 mcg monthly IM or 1,000–2,000 mcg daily oral	Baseline serum B12; monitor annually
Folate (B9)	Low intake from reduced food volume increases homocysteine risk	400–800 mcg daily as methylfolate	Baseline RBC folate; assess if history of anemia
Iron	Reduced stomach acid impairs ferrous absorption; women at higher risk	18–27 mg daily ferrous sulfate or bisglycinate form	Baseline serum ferritin and TIBC; monitor if heavy periods
Calcium + Vitamin D	GLP-1 reduces calcium-rich food intake and absorption; bone loss risk over 12+ months	1,000–1,200 mg calcium; 1,000–2,000 IU vitamin D3 daily	Baseline 25-OH vitamin D; consider DEXA if long-term therapy

Genetic Predispositions and Individual Micronutrient Vulnerabilities

Variations in genes affecting nutrient absorption, metabolism, and utilization influence how quickly deficiencies develop on semaglutide. For example, genetic variants in folate metabolism pathways or iron-handling genes may predict increased supplementation needs or absorption challenges during GLP-1 therapy.

PlexusDx's Precision Peptide Genetic Test reveals predispositions in nutrient-metabolism pathways relevant to GLP-1 users. These insights may help guide conversations with your provider about whether higher baseline micronutrient screening or more aggressive supplementation timing is warranted before starting or optimizing your treatment.

Timing, Form, and Safety Considerations for Micronutrient Supplementation

Supplement timing and form matter significantly on semaglutide. B12 injections bypass absorption challenges; oral B12 requires intrinsic factor. Iron should be taken with vitamin C on an empty stomach for absorption but may cause nausea. Calcium and iron compete for absorption and must be spaced 2+ hours apart to maximize uptake.

Before starting supplementation, consult your healthcare provider about baseline micronutrient levels, drug interactions, and whether you have conditions (e.g., hemochromatosis, kidney disease) that alter supplementation safety. Your provider can order appropriate baseline biomarkers and recommend a schedule aligned with your semaglutide dosing and individual risk profile.

How PlexusDx Supports a More Personalized Approach

PlexusDx recognizes that nutritional demands during GLP-1 therapy are not one-size-fits-all. Genetic predispositions in nutrient-absorption pathways, metabolic efficiency, and even appetite regulation genes influence how semaglutide affects your micronutrient status. This context may help provide a more informed foundation for conversations with your provider about supplementation priorities.

The Precision Peptide Genetic Test examines variants in key metabolic pathways relevant to GLP-1 users, including genes affecting folate utilization, iron metabolism, and nutrient absorption efficiency. While the test does not predict exact micronutrient deficiency risk, it may help highlight genetic factors that inform whether aggressive screening or supplementation timing is appropriate for your situation.

Combining genetic insights with baseline biomarker data—serum B12, folate, iron, vitamin D, and calcium—enables a truly personalized supplementation plan. PlexusDx helps you understand your genetic predispositions so you can have a more informed conversation with your healthcare provider about micronutrient needs before, during, and after semaglutide therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $229-$509/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.